Pressure On CMS To Add UDI To Claims Forms Continues
This article was originally published in The Gray Sheet
Executive Summary
The West Health Institute has joined a group of stakeholders calling for incorporating Unique Device Identifier codes in reimbursement claims forms to improve postmarket surveillance. But hospital and physician groups continue to push against the notion, stating it would create unnecessary burdens.
You may also be interested in...
Leveraging Registries: A Next Step In National Post-Market Plan
FDA is making a major push as part of its new post-market surveillance strategy to make better use of existing national patient registries, while avoiding imposition of additional mandatory device registries.
Finding The Sweet Spot For Real-World Evidence: Aetion Stresses Early Feasibility Assessment
Robust natural history data sets with well-chosen outcomes are fundamental in Aetion’s regulatory feasibility tool for real-world evidence, built through analysis of US FDA case studies and guidance.
FDA Gene Therapy Office Chief Prefers Flexibility With Accelerated Approval Confirmatory Trials
Ideally, the studies would be underway at the time of approval, as the US FDA’s new authority allows, but Office of Therapeutic Products Director Nicole Verdun sys there will be exceptions.